Depression linked to E-cigarettes and cigarette use among college students

Jul.15.2022
Depression linked to E-cigarettes and cigarette use among college students
Depression linked to tobacco use among college students, according to study in Psychiatry Research Communications.

A study published in the Journal of Psychiatric Research found a positive correlation between depression and tobacco product use, including electronic and traditional cigarettes, among college students.


This study analyzed data from the Fall 2020 cohort of the Healthy Minds Study, which collected information on the psychological health of undergraduate and graduate students, as well as sociodemographic covariates and other relevant factors. The online survey was distributed to 36 universities across the United States between September and December 2020. Five of these universities included drug use in the survey, resulting in a sample size of 2,115 for this study.


Attendees reported on individuals who exclusively use e-cigarettes, exclusively use traditional cigarettes, and those who use a combination of both. The symptoms of depression were measured using the Patient Health Questionnaire-9 (PHQ-9) for the participants. The PHQ-9 questionnaire scores the answers on a scale ranging from 0 to 27, with scores above 5 indicating possible depression.


The study measures societal norms surrounding tobacco use and perceptions of risks associated with tobacco use. In order to gauge societal norms, participants were asked to estimate the percentage of college students who smoke. Responses to questions about tobacco risks were measured on a scale of 1 to 4, with 1 indicating "no risk" and 4 indicating "high risk.


Using logistic regression analysis, this study examines the social norms of tobacco use among individuals with symptoms of depression, perceived risk of smoking, and those who use both traditional cigarettes and e-cigarettes.


The average age of participants was 23.41±7.84 years, with 43.8% being female and 85.6% being white. Participants reported that in the past 30 days, 22.38% only used e-cigarettes, 7.89% only used traditional cigarettes, and 2.72% used a combination of both.


A study has found that 33.1% of participants met the criteria for possible depression, with an average score of 8.00 ± 6.33. The levels of depression were higher among all groups who used tobacco products: those who only used e-cigarettes (OR, 1.08; 95%CI, 1.06-1.10), those who only smoked traditional cigarettes (OR, 1.09; 95%CI, 1.06-1.12), and those who used both (OR, 1.05; 95%CI, 1.00-1.10).


Participants reported medium risks associated with smoking and vaping, with average scores of 3.26 ± 1.01 and 2.85 ± 0.98, respectively. The perceived social norms related to the use of electronic cigarettes (OR, 1.01; 95% CI 1.00-1.02) and cigarettes (OR, 1.02; 95% CI, 1.00-1.03) were higher and associated with increased use of these tobacco products.


Most participants in the study were white students, so the results may not be representative. Although the researchers emphasized the confidentiality of the responses, students may have underreported their tobacco use.


Overall, researchers have concluded that there is a link between depression and both e-cigarettes and traditional cigarettes. They have found that the likelihood of using e-cigarettes and traditional cigarettes is positively associated with the likelihood of depression.


The researchers stated that gaining further knowledge on psychosocial and mental health related factors could provide valuable information in understanding the smoking habits and associated risks in college students. This understanding can guide the development of smoking cessation policies.


I'm sorry, but without any text to translate, I cannot provide a response.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

AIR Romania Manufacturing Facility Expected to Begin Operations in Q1 2027
AIR Romania Manufacturing Facility Expected to Begin Operations in Q1 2027
AIR Limited announced on May 7, 2026, that it plans to open a new manufacturing facility of approximately 70,000 square feet in Stefanesti, Bucharest North, Romania. The facility is expected to begin operations by the first quarter of 2027. AIR said that once fully operational, the facility is expected to support more than 150 jobs and be capable of producing more than 4,000 tons of flavored shisha molasses each year.
May.08 by 2FIRSTS.ai
Canada Recalls Siberia and ZYN Nicotine Pouches Over Unauthorized Sales
Canada Recalls Siberia and ZYN Nicotine Pouches Over Unauthorized Sales
Health Canada has issued a nationwide recall for nicotine pouch products sold under the Siberia and ZYN brands, citing a lack of market authorization. All affected lots are subject to the recall.
Jun.15
EU Launches Online Feedback as TPD Revision Enters New Milestone
EU Launches Online Feedback as TPD Revision Enters New Milestone
The European Commission has opened an online call for evidence on revising EU tobacco products and advertising rules, marking a new phase in the TPD/TAD review. Policy options may cover novel products, flavours, packaging, digital marketing and advertising. A 2Firsts review of 855 early submissions shows rapid engagement and recurring debate over differentiated regulation, harm reduction, youth protection, illicit trade and economic impact.
Special Report
May.21
NielsenIQ and Goldman Sachs Data Show Smokeless Was the Only Growing Major U.S. Nicotine Category
NielsenIQ and Goldman Sachs Data Show Smokeless Was the Only Growing Major U.S. Nicotine Category
NielsenIQ and Goldman Sachs data show U.S. smokeless nicotine product sales rose more than 8% year over year in the 52 weeks ended May 30, making it the only major nicotine category to record growth.
Market
Jun.23
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
mperial Brands’ HY26 results point to a more selective NGP transition. The company is using cash flow from traditional tobacco to fund targeted investments in modern oral nicotine, heated tobacco and reusable vaping systems. Its decision to exit the legacy myblu vaping business in the U.S., while expanding Zone nicotine pouches. In Europe, Imperial’s NGP growth is being driven by a multi-category portfolio including blu, Pulze and Zone/Skruf.
Special Report
May.12